EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Risk of hemorrhagic stroke in warfarin‐treated patients following heart valve replacement: Findings from the MAGPIE study

Dipannita Adhikary, Md Abdullah Yusuf iD, Am Nayeem Parvez, Sheikh M B Faruque, Santo Barman, Adneen Moureen, Luke J Rogers, Aziz Momin, Venkatachalam Chandrasekaran, Asit B Adhikary, Redoy Ranjan iD

Ibrain · 2026-06 · 12 (2) · 250-258

DOI: 10.1002/ibra.70020 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Ibrain, online erschienen am 17.05.2026. Verfasst von Dipannita Adhikary und 10 weiteren Autor:innen. Beteiligte Einrichtung: Department of Biological Sciences Royal Holloway University of London London UK. Die Arbeit nennt 40 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: General Motors Corporation.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Hemorrhagic stroke (HS) remains a serious and potentially disabling complication following heart valve replacement (HVR). We aimed to evaluate the incidence and predictors of HS among mechanical HVR patients in Bangladesh. The Multidimensional Approach of Genotype and Phenotype In Stroke Etiology (MAGPIE) is an ambispective study recruited 568 consecutive HVR patients who had long‐term (≥6 months) warfarin therapy between January 2010 and December 2024. Among the 568 HVR patients, 4.4% experienced HS, with a mortality rate of 52%, and the median age was 40 years (interquartile range [IQR]: 32–45). The median duration of warfarin uses among mechanical heart valve patients with HS varied by procedure: 63 months (IQR: 48–86) for mitral valve replacement, 60 months (12–85) for aortic valve replacement, 96 months (52–101.50) for double valve replacement, and 42 months (24–60) for patients undergoing coronary artery bypass grafting (CABG) with valve replacement. Additionally, a receiver operating characteristic curve analysis identified 104 months as the discriminatory threshold for warfarin therapy duration in predicting post‐HVR HS onset. An age‐ and sex‐adjusted logistic regression model identified severe pulmonary hypertension (odds ratio [OR] 4.44; 95% confidence interval [CI] 1.15–17.04; p = 0.02) and warfarin therapy duration ≥104 months (OR 1.99; 95% CI 1.00–3.76; p = 0.04) as independent predictors of HS in patients with mechanical HVR. Severe pulmonary hypertension was associated with a 4.4‐fold higher risk and warfarin therapy beyond 104 months with a twofold higher risk of HS among patients with mechanical HVR.

Schlagwörter

Stichwörter der Autor:innen

Bangladeshheart valve replacementhemorrhagic strokemechanical valvemortality

Autor:innen und Institutionen

  • Department of Biological Sciences Royal Holloway University of London London UK.
  • Department of Microbiology National Institute of Neurosciences and Hospital Dhaka Bangladesh.
  • Department of Cardiac Surgery Impulse Hospital and Research Centre Dhaka Bangladesh.
  • Department of Cardiac Surgery National Institute of Cardiovascular Diseases Dhaka Bangladesh.
  • Department of Microbiology Armed Forces Medical College Dhaka Bangladesh.
  • Department of Cardiothoracic Surgery, Academic Cardiovascular Unit South Tees NHS Foundation Trust Middlesbrough UK.

ORCID-Profile: Md Abdullah Yusuf, Redoy Ranjan

Förderung

  • General Motors Corporation

Zitieren

APA

Adhikary, D., Yusuf, M. A., Parvez, A. N., Faruque, S. M. B., Barman, S., Moureen, A., Rogers, L. J., Momin, A., Chandrasekaran, V., Adhikary, A. B., & Ranjan, R. (2026). Risk of hemorrhagic stroke in warfarin‐treated patients following heart valve replacement: Findings from the MAGPIE study. Ibrain, 12(2), 250-258. https://doi.org/10.1002/ibra.70020

Vancouver

Adhikary D, Yusuf MA, Parvez AN, Faruque SMB, Barman S, Moureen A, et al. Risk of hemorrhagic stroke in warfarin‐treated patients following heart valve replacement: Findings from the MAGPIE study. Ibrain. 2026;12(2):250-258. doi:10.1002/ibra.70020

BibTeX
@article{Adhikary2026,
  author = {Adhikary, Dipannita and Yusuf, Md Abdullah and Parvez, Am Nayeem and Faruque, Sheikh M B and Barman, Santo and Moureen, Adneen and Rogers, Luke J and Momin, Aziz and Chandrasekaran, Venkatachalam and Adhikary, Asit B and Ranjan, Redoy},
  title = {Risk of hemorrhagic stroke in warfarin‐treated patients following heart valve replacement: Findings from the MAGPIE study},
  journal = {Ibrain},
  year = {2026},
  volume = {12},
  number = {2},
  pages = {250--258},
  doi = {10.1002/ibra.70020}
}
Kostenlos starten →